Guo Y - Search Results

1

The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs.

Jones SP, Tang XL, Guo Y, Steenbergen C, Lefer DJ, Kukreja RC, Kong M, Li Q, Bhushan S, Zhu X, Du J, Nong Y, Stowers HL, Kondo K, Hunt GN, Goodchild TT, Orr A, Chang CC, Ockaili R, Salloum FN, Bolli R. Jones SP, et al. Among authors: guo y. Circ Res. 2015 Feb 13;116(4):572-86. doi: 10.1161/CIRCRESAHA.116.305462. Epub 2014 Dec 11. Circ Res. 2015. PMID: 25499773 Free PMC article.

2

MCC-134, a single pharmacophore, opens surface ATP-sensitive potassium channels, blocks mitochondrial ATP-sensitive potassium channels, and suppresses preconditioning.

Sasaki N, Murata M, Guo Y, Jo SH, Ohler A, Akao M, O'Rourke B, Xiao RP, Bolli R, Marbán E. Sasaki N, et al. Among authors: guo y. Circulation. 2003 Mar 4;107(8):1183-8. doi: 10.1161/01.cir.0000051457.64240.63. Circulation. 2003. PMID: 12615799 Free PMC article.

3

Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.

Li Q, Guo Y, Xuan YT, Lowenstein CJ, Stevenson SC, Prabhu SD, Wu WJ, Zhu Y, Bolli R. Li Q, et al. Among authors: guo y. Circ Res. 2003 Apr 18;92(7):741-8. doi: 10.1161/01.RES.0000065441.72685.29. Circ Res. 2003. PMID: 12702642 Free PMC article.

4

Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction.

Stein AB, Guo Y, Tan W, Wu WJ, Zhu X, Li Q, Luo C, Dawn B, Johnson TR, Motterlini R, Bolli R. Stein AB, et al. Among authors: guo y. J Mol Cell Cardiol. 2005 Jan;38(1):127-34. doi: 10.1016/j.yjmcc.2004.10.006. Epub 2004 Dec 8. J Mol Cell Cardiol. 2005. PMID: 15623429 Free PMC article.

5

Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS.

Guo Y, Stein AB, Wu WJ, Zhu X, Tan W, Li Q, Bolli R. Guo Y, et al. Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H2251-7. doi: 10.1152/ajpheart.00341.2005. Epub 2005 Jul 8. Am J Physiol Heart Circ Physiol. 2005. PMID: 16006548 Free PMC article.

6

Role of the protein kinase C-epsilon-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning.

Xuan YT, Guo Y, Zhu Y, Wang OL, Rokosh G, Messing RO, Bolli R. Xuan YT, et al. Among authors: guo y. Circulation. 2005 Sep 27;112(13):1971-8. doi: 10.1161/CIRCULATIONAHA.105.561522. Epub 2005 Sep 19. Circulation. 2005. PMID: 16172266 Free PMC article.

7

The late phase of preconditioning and its natural clinical application--gene therapy.

Bolli R, Li QH, Tang XL, Guo Y, Xuan YT, Rokosh G, Dawn B. Bolli R, et al. Among authors: guo y. Heart Fail Rev. 2007 Dec;12(3-4):189-99. doi: 10.1007/s10741-007-9031-4. Heart Fail Rev. 2007. PMID: 17541820 Free PMC article. Review.

8

Endothelial nitric oxide synthase plays an obligatory role in the late phase of ischemic preconditioning by activating the protein kinase C epsilon p44/42 mitogen-activated protein kinase pSer-signal transducers and activators of transcription1/3 pathway.

Xuan YT, Guo Y, Zhu Y, Wang OL, Rokosh G, Bolli R. Xuan YT, et al. Among authors: guo y. Circulation. 2007 Jul 31;116(5):535-44. doi: 10.1161/CIRCULATIONAHA.107.689471. Epub 2007 Jul 2. Circulation. 2007. PMID: 17606840 Free PMC article.

9

Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis.

Hu X, Dai S, Wu WJ, Tan W, Zhu X, Mu J, Guo Y, Bolli R, Rokosh G. Hu X, et al. Among authors: guo y. Circulation. 2007 Aug 7;116(6):654-63. doi: 10.1161/CIRCULATIONAHA.106.672451. Epub 2007 Jul 23. Circulation. 2007. PMID: 17646584 Free PMC article.

10

Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway.

Li Q, Guo Y, Tan W, Ou Q, Wu WJ, Sturza D, Dawn B, Hunt G, Cui C, Bolli R. Li Q, et al. Among authors: guo y. Circulation. 2007 Oct 2;116(14):1577-84. doi: 10.1161/CIRCULATIONAHA.107.689810. Epub 2007 Sep 4. Circulation. 2007. PMID: 17785622 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41,414 results

Search Page